Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Outset Medical Inc OM

Technology Scientific & Technical Instruments
Outset Medical, Inc. is a medical technology company. It offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. It designed Tablo from the ground up to be a single enterprise solution that can be... see more

Recent & Breaking News (NDAQ:OM)

Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

GlobeNewswire 10 days ago

Outset Medical Appoints Renee Gaeta as Chief Financial Officer

GlobeNewswire 12 days ago

Outset Medical Appoints Industry Veteran Kevin O'Boyle to its Board of Directors

GlobeNewswire May 14, 2025

Outset Medical to Present at RBC Global Healthcare Conference

GlobeNewswire May 9, 2025

Outset Medical First-Quarter Results Demonstrate Strong Growth in Console and Recurring Revenue as Gross Margin Expanded and Cash Use Declined

GlobeNewswire May 7, 2025

Outset Medical to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025

GlobeNewswire April 16, 2025

Shareholder Alert: Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Outset Medical, Inc. (OM)

Newsfile March 25, 2025

Outset Medical Announces One-for-Fifteen Reverse Stock Split

GlobeNewswire March 18, 2025

Outset Medical to Present at the 45th Annual TD Cowen Health Care Conference

GlobeNewswire February 24, 2025

Outset Medical Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire February 19, 2025

Outset Medical Announces Resolution of Warning Letter

GlobeNewswire February 13, 2025

Outset Medical to Report Fourth Quarter and Full-Year 2024 Financial Results on Wednesday, February 19, 2025

GlobeNewswire February 3, 2025

Outset Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 8, 2025

Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and Healthcare Institutional Investors

GlobeNewswire January 6, 2025

Kuehn Law Encourages Investors of Outset Medical, Inc. to Contact Law Firm

Newsfile December 31, 2024

Grabar Law Office Investigates Claims on Behalf of Shareholders of Outset Medical, Inc. (OM)

Newsfile December 5, 2024

Outset Medical to Present at the 2024 Stifel Healthcare Conference

GlobeNewswire November 15, 2024

Grabar Law Office Investigates Claims on Behalf of Shareholders of Outset Medical, Inc. (OM)

Newsfile November 9, 2024

Outset Medical Reports Third Quarter 2024 Financial Results

GlobeNewswire November 6, 2024

Contact Levi & Korsinsky by October 28, 2024 Deadline to Join Class Action Against Outset Medical, Inc.(OM)

ACCESS Newswire October 28, 2024